Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-09-002710
Filing Date
2009-03-16
Accepted
2009-03-16 12:13:58
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2191667z10-k.htm 10-K 1050240
2 EXHIBIT 10.56 a2191667zex-10_56.htm EX-10.56 573334
3 EXHIBIT 23.1.1 a2191667zex-23_11.htm EX-23.1.1 3735
4 EXHIBIT 31.1.1 a2191667zex-31_11.htm EX-31.1.1 14024
5 EXHIBIT 31.2.1 a2191667zex-31_21.htm EX-31.2.1 14009
6 EXHIBIT 32.1.1 a2191667zex-32_11.htm EX-32.1.1 7616
7 G139305.JPG g139305.jpg GRAPHIC 50534
8 G424152.JPG g424152.jpg GRAPHIC 16830
9 G1027083.JPG g1027083.jpg GRAPHIC 13227
  Complete submission text file 0001047469-09-002710.txt   1775835
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

EIN.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32966 | Film No.: 09683153
SIC: 2836 Biological Products, (No Diagnostic Substances)